Carotid ultrasound findings in rheumatoid arthritis and control subjects: A case-control study
Martin I. Wah-Suarez
Internal Medicine Department, University Hospital Dr.Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorCorresponding Author
Dionicio A. Galarza-Delgado
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Correspondence
Dionicio A. Galarza-Delgado, Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico.
Email: [email protected]
Search for more papers by this authorJose R. Azpiri-Lopez
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorIris J. Colunga-Pedraza
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorEstefania E. Abundis-Marquez
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorJose A. Davila-Jimenez
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorCinthia Y. Guillen-Gutierrez
Department of Radiology and Medical Imaging, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorGuillermo Elizondo-Riojas
Department of Radiology and Medical Imaging, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorMartin I. Wah-Suarez
Internal Medicine Department, University Hospital Dr.Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorCorresponding Author
Dionicio A. Galarza-Delgado
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Correspondence
Dionicio A. Galarza-Delgado, Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico.
Email: [email protected]
Search for more papers by this authorJose R. Azpiri-Lopez
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorIris J. Colunga-Pedraza
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorEstefania E. Abundis-Marquez
Internal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorJose A. Davila-Jimenez
Internal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorCinthia Y. Guillen-Gutierrez
Department of Radiology and Medical Imaging, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorGuillermo Elizondo-Riojas
Department of Radiology and Medical Imaging, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Monterrey, Mexico
Search for more papers by this authorAbstract
Abstract Rheumatoid arthritis (RA) is a chronic, inflammatory disease closely linked with atherosclerosis. Recommended cardiovascular disease (CVD) integral evaluation includes screening for asymptomatic atherosclerosis plaques with carotid ultrasound (US). The aim of this study is to evaluate the carotid US characteristics, including carotid intima media thickness (cIMT) and carotid plaque (CP), and compare RA-patients and controls in a Mexican-mestizo population.
Method
Prospective cross-sectional, observational study comparing RA-patients and matched controls without RA. Medical history and physical exam was performed in all subjects by a rheumatologist and two clinical blinded radiologists did the carotid US. Increased cIMT was defined as ≥0.9 mm. CP was defined as a focal narrowing ≥0.5 mm of the surrounding lumen or a cIMT ≥1.2 mm. Multivariable analysis was done comparing RA-patients and control subjects characteristics with carotid US.
Result
In the final analysis 209 patients were included, 103 patients with RA and 106 controls. Bilateral CP was found more than twice in RA than controls (15.5% vs 6.6%). Unilateral CP was more common in either side evaluated, being heterogeneous plaques the most common in RA-patients. The prevalence of increased cIMT was found higher in RA-patients either in both sides (right 37.9% vs 15.1%, P = 0.00; left 43.7% vs 19.8%, P = 0.00) were statistically significant.
Conclusion
It was confirmed that RA-patients have greater subclinical atherosclerosis represented in the carotid US measuring cIMT and CP as surrogates. RA-patients with subclinical atherosclerotic disease have more heterogeneous plaques characteristics.
REFERENCES
- 1del Rincón I, Polak JF, Leary DHO, et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis. 2015; 74: 1118-1123.
- 2Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003; 107: 1303-1307.
- 3Lindhardsen J, Ahlehoff O, Gislason GH, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus : a Danish nationwide cohort study. Ann Rheum Dis. 2011; 70: 929-934.
- 4Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D, Avina-zubieta JA. Risk of incident cardiovascular events in patients with rheumatoid arthritis : a meta-analysis of observational studies. Ann Rheum Dis. 2012; 71: 1524-1529.
- 5Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of in fl ammatory joint disorders : 2015/2016 update. Ann Rheum Dis. 2017; 76: 17-28.
- 6Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA. Carotid ultrasound is useful for the cardiovascular risk strati fi cation of patients with rheumatoid arthritis : results of a population-based study. Ann Rheum Dis. 2014; 73: 722-727.
- 7Corrales A, Parra JA, González-Juanatey C, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2013; 72(11): 1764-1770.
- 8Jain A, McClelland R, Polak J, et al. Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women. Circ Cardiovasc Imaging. 2012; 4(1): 8-15.
- 9Zhang H, Liu M, Ren T, Wang X, Liu D. Associations between carotid artery plaque score, carotid hemodynamics and coronary heart disease. Int J Environ Res Public Health. 2015; 12: 14275-14284.
- 10Evans M, Escalante A, Battafarano D, Leary DHO, Rincón I. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum. 2011; 63(5): 1211-1220.
- 11Semb AG, Ikdahl E, Hisdal J, Olsen IC, Rollefstad S. Exploring cardiovascular disease risk evaluation in patients with in fl ammatory joint diseases. Int J Cardiol. 2016; 223: 331-336.
- 12Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K. Interventional cardiology Carotid artery intima-media thickness and plaque score can predict the SYNTAX score. Eur Heart J. 2011; 33: 113-119.
- 13Romero JR, Preis SR, Beiser A, et al. Carotid atherosclerosis and cerebral microbleeds: the Framingham. J Am Heart Assoc. 2016; 5: e002377. https://doi.org/10.1161/JAHA.115.002377.
- 14Gonzalez-Juanatey C, Llorca J. Predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2009; 38(5): 366-371.
- 15 American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes 2017. Diabetes Care 2017; 40(Suppl. 1): S11-S24.
- 16 European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32: 1769-1818.
- 17 ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013; 31: 1925-1938.
- 18Aletaha D. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007; 21(4): 663-675.
- 19Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008; 21(2): 93-111.
- 20Naqvi TZ, Lee M-S. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014; 7(10): 1025-1038.
- 21Tam L, Shang Q, Li EK, et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum. 2008; 59(9): 1322-1331.
- 22Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women. Stroke. 1999; 30: 841-850.
- 23Yu C, Zhang Q, Lam L, et al. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal–medial thickness in patients with coronary heart disease. Heart. 2007; 93: 933-939.
- 24Mateo I, Andrade H, Morillas P, Quiles J. What measure of carotid wall thickening is the best atherosclerotic loading score in the hypertensive patient: maximum or mean value? Rev Esp Cardiol. 2016; 64(5): 417-420.
10.1016/j.recesp.2010.06.007 Google Scholar
- 25Plantinga Y, Dogan S, Grobbee DE, Bots ML. Carotid intima-media thickness measurement in cardiovascular screening programmes. Eur J Cardiovasc Prev Rehabil. 2009; 16: 639-644.
- 26Daviglus ML, Talavera GA, Avile ML, et al. Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States. 2015.
- 27Van Sijl AM, Peters MJ. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011; 40(5): 389-397.
- 28Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003; 82(6): 407-413.
- 29López-Mejías R, Castañeda S, González-Juanatey C, et al. Autoimmunity reviews cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev. 2016; 15: 1013-1030.
- 30Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015; 13: 46.
- 31Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrua C, Testa A, Llorca JHigh-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol. 2005; 32(7): 1219-1223.
- 32Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA – DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid. Arthritis. 2007; 57(1): 125-132.
- 33Corrales A, Dessein PH, Tsang L, et al. Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study. Arthritis Res Ther. 2015; 17: 55.
- 34Dehghan P, Rajaei A, Moeineddin R. Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis. Clin Rheumatol. 2015; 34: 1363-1366.
- 35Chung CP, Oeser A, Raggi P, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheumatol. 2005; 52(10): 3045-3053.
- 36Liu J, Ng M, Cheung T, Chung H, Chen Y. Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. Clin Rheumatol. 2017; 36: 807-816.
- 37Pedro LMÃ, Fernandes JF, Pedro MM, et al. Ultrasonographic risk score of carotid plaques. Eur J Vasc Endovasc Surg. 2002; 498: 492-498.
- 38Petersen C, Peçanha PB, Venneri L, Pasanisi E, Pratali L, Picano E. The impact of carotid plaque presence and morphology on mortality outcome in cardiological patients. Cardiovasc Ultrasound. 2006; 4: 16.
- 39Brinjikji W, Rabinstein AA, Lanzino G, et al. Ultrasound characteristics of symptomatic carotid plaques: a systematic review and meta-analysis. Cerebrovasc Dis. 2015; 40: 165-174.
- 40Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol. 2013; 40(4): 359-368.
- 41Myasoedova E, Chandran A, Ilhan B, et al. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis. 2016; 75: 560-565.
- 42Dessein PH, Corrales A, Lopez-Mejias R, et al. The Framingham score and the systematic coronary risk evaluation at low cutoff values are useful surrogate markers of high-risk subclinical atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2016; 43(3): 486-494.
- 43Kurt T, Temiz A, Gokmen F, Adam G, Ozcan S, Ozbudak E. Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis ? Wien Klin Wochenschr. 2015; 127: 529-534.
- 44Fent GJ, Greenwood JP, Plein S, Buch MH. The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis : where we are and where we need to be. Ann Rheum Dis. 2017; 76: 1169-1175.
- 45Cuspidia C, Salac C, Provenzanod F, et al. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2017; 35: 1-8.
- 46Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2011; 57(8): e16-e94.